Globe Newswire

Egan-Jones joins ISS in Recommending Shareholders Vote “FOR” ONLY Crown Castle’s 12 Highly Qualified Nominees on the WHITE Proxy Card or Voting Instruction Form

Crown Castle Board Urges Shareholders to Vote TODAY; May 22nd Annual Meeting is Fast Approaching

HOUSTON, May 20, 2024 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Crown Castle” or the “Company”) today announced that proxy advisory firm Egan-Jones has joined Institutional Shareholder... (continue reading...)

TROY, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that Agrify Corporation and Nature’s Miracle Holdings Inc. (NASDAQ: NMHI) (“Nature’s Miracle”) have mutually agreed to terminate the agreement and plan of merger, previously announced on May 16, 2024, given unfavorable market... (continue reading...)

Generated record Q1 programmatic revenue, 34% year-over-year Adjusted EBITDA growth, and $37.7 million net cash from operating activities

Reaffirming full year 2024 Contribution ex-TAC and Adjusted EBITDA guidance

Completed $20 million Ordinary share repurchase program and launched additional $50 million program

Strengthened balance sheet through repayment of outstanding $100 million long-term debt

NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Nexxen International... (continue reading...)

• Reunion’s lead asset, RE104, is a potential best-in-class, clinical-stage serotonergic psychedelic drug candidate designed as a safe, fast-acting, short duration therapy to provide lasting benefits to patients with underserved mental health disorders

• RE104 has shown it is an efficient prodrug for the delivery of 4-HO-DiPT, a unique short-duration psychedelic with potential in depressive disorders
• Company expects to start enrolling patients this quarter... (continue reading...)

LOUISVILLE, Ky., May 20, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud that its company, Onco360®, one of the nation’s largest independent oncology pharmacies, is being selected as a pharmacy partner by Day One Biopharmaceuticals for OJEMDA™, a cutting-edge treatment for children diagnosed with certain central nervous system tumors.

The FDA-approved treatment is... (continue reading...)